Palatin Technologies (PTN) Capital Expenditures (2012 - 2026)
Palatin Technologies' (PTN) quarterly Capital Expenditures came in at $38483.0 in Q1 2026, up 683.61% on a QoQ basis from $4911.0 in Q2 2024.
Palatin Technologies (PTN) Capital Expenditures (2012 - 2026) Analysis & Trends
Palatin Technologies (PTN) has 11 years of Capital Expenditures data on file, last reported at $38483.0 in Q1 2026.
- Quarterly Capital Expenditures changed N/A year-over-year to $38483.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $43394.0 (up 2.04% YoY) and the FY2024 annual result came in at $42526.0, down 90.2% from the prior year.
- Capital Expenditures climbed to $38483.0 in Q1 2026, from $4911.0 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $141228.0 in Q3 2022 to a low of $4911.0 in Q2 2024.
- A 4-year average of $69938.7 and a median of $52396.0 in 2023 frame the typical range for Capital Expenditures.
- Annual changes were most pronounced in 2022 — Capital Expenditures soared 3711500.0% — and 2024, when it sank 90.63%.
- Tracing PTN's Capital Expenditures over 4 years: stood at $123428.0 in 2022, then tumbled by 69.52% to $37615.0 in 2023, then plunged by 86.94% to $4911.0 in 2024, then surged by 683.61% to $38483.0 in 2026.
- The last three Capital Expenditures figures came in at $38483.0 (Q1 2026), $4911.0 (Q2 2024), and $37615.0 (Q4 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.93 Bn | 131.07 Bn | 2.84 Bn | 112.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.91 Bn | 77.92 Bn | 3.93 Bn | 240.20 Mn |
| 3 | Argenx Se | 64.98 Bn | 59.80 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.86 Bn | 53.72 Bn | 52.00 Mn | 37.00 Mn |
| 5 | BeOne Medicines | 42.03 Bn | 36.93 Bn | 1.53 Bn | 25.02 Mn |
| 6 | Alnylam Pharmaceuticals | 31.54 Bn | 28.23 Bn | 992.69 Mn | 34.68 Mn |
| 7 | BioNTech SE | 27.88 Bn | 9.49 Bn | 668.28 Mn | -73.57 Mn |
| 8 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn | 6.26 Mn |
| 9 | Royalty Pharma | 27.35 Bn | 26.51 Bn | - | 251.02 Mn |
| 10 | Palatin Technologies | 40.37 Mn | 40.37 Mn | - | 38,483.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 38,483.00 |
| Mar 31, 2026 | 38,483.00 |
| Jun 30, 2024 | 4,911.00 |
| Jun 30, 2024 | 4,911.00 |
| Dec 31, 2023 | 37,615.00 |
| Dec 31, 2023 | 37,615.00 |
| Jun 30, 2023 | 52,396.00 |
| Jun 30, 2023 | 52,396.00 |
| Mar 31, 2023 | 116,875.00 |
| Mar 31, 2023 | 116,875.00 |
| Dec 31, 2022 | 123,428.00 |
| Dec 31, 2022 | 123,428.00 |
| Sep 30, 2022 | 141,228.00 |
| Sep 30, 2022 | 141,228.00 |
| Jun 30, 2022 | 37,116.00 |
| Jun 30, 2022 | 37,116.00 |
| Mar 31, 2022 | 77,396.00 |
| Mar 31, 2022 | 77,396.00 |
| Dec 31, 2021 | 89,098.00 |
| Dec 31, 2021 | 89,098.00 |